France· FR:67189273
MULTIHANCE 0,5 mmol/mL, solution injectable (IV)
A medicinal product containing gadobénate de diméglumine, registered in France by BRACCO IMAGING FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GADOBÉNATE DE DIMÉGLUMINE
- Manufacturer
- BRACCO IMAGING FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009347412961 flacon(s) en verre de 10 ml
- cip1334009347413571 flacon(s) en verre de 15 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadobénate de diméglumine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMULTIHANCEBracco Imaging Deutschland GmbH, Konstanz
- BelgiumMultihance 0.5 mmol/mlBracco Imaging Deutschland
- United KingdomMultiHance 0.5mmol/ml solution for injection 10ml vialsBracco UK Ltd
- IrelandMultiHance 529 mg/ml solution for injection in pre-filled syringeBracco Imaging spa
- GermanyMultihanceEurocontrast Gmbh
- SwedenMultiHance 334 mg/ml Injektionsvätska, lösningBracco Imaging SpA
- United StatesMultiHanceBRACCO DIAGNOSTICS INC
- CanadaMULTIHANCEBRACCO IMAGING CANADA
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Multihance
- Belgium · Multihance
- Czechia · Multihance
- Germany · Multihance
- Denmark · Multihance
- Spain · Multihance
- Finland · Multihance
- United Kingdom (Northern Ireland) · Multihance
- Greece · Multihance
- Croatia · Multihance
- Hungary · Multihance
- Ireland · Multihance
- Italy · Multihance
- Luxembourg · Multihance
- Netherlands · Multihance
- Norway · Multihance
- Poland · Multihance
- Portugal · Multihance
- Romania · Multihance
- Sweden · Multihance
- Slovenia · Multihance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55c90739-d7fc-43d8-8b24-a4c090ef39cc GET /v1/drugs/55c90739-d7fc-43d8-8b24-a4c090ef39cc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67189273",
"date_amm": "1998-06-02",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "GADOBÉNATE DE DIMÉGLUMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about gadobénate de diméglumine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.